Dr. Concepcion on Barriers to Genetic Testing in Community Urology Practices

Video

Raoul S. Concepcion, MD, FACS, discusses barriers to genetic testing for patients with prostate cancer as identified by community urologists.

Raoul S. Concepcion, MD, FACS, director, Comprehensive Prostate Center, discusses barriers to genetic testing for patients with prostate cancer as identified by community urologists.

Of the 52 urology practices that participated in an 8-question online survey, 32 are currently offering genetic testing to patients who qualify; however, there are several challenges that providers encounter in clinic.

The number 1 challenge identified by 22% of practices concerns medical or legal liability for results that go unaddressed, explains Concepcion.

Secondly, 20% of practices were apprehensive about patient expenses and reimbursement. This is perhaps a reflection of tissue-based somatic testing expenses, says Concepcion.

Finally, the third most commonly cited concern identified by 18% of practices relates to the difficulty of obtaining a complete family history. Historically, urologists have not had to acquire this information; however, it is vital for genetic testing, concludes Concepcion.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD